Engin GERÇEKER, Kaan YILDIZ, Muhammed Akif ATLAN, Sedef ÖKSÜZ, Cem KARADENİZ
Trends in Pediatrics - 2026;7(2):102-108
Objective: Advances in transcatheter closure device materials ensure safety and long-term effectiveness in most atrial septal defect (ASD) cases. Methods: This single-center study retrospectively evaluated outcomes in 26 pediatric patients who underwent transcatheter ASD closure between 2023 and 2025. Transcatheter closure was attempted using the Occlutech(R) Figulla Flex II ASD Occluder (OFSO). Follow-up evaluations of device-specific outcomes, procedural success rates, and complications were recorded. Results: The average age of the patients was 9.3 +/- 4.1 years, and 61.5% were girls. Of the total patients, 11.5% had a large defect. A complication occurred in 1 patient (3.8%). Conclusion: Transcatheter closure of ASD with the OFSO device is a safe and effective treatment strategy for children, demonstrating a high procedural success rate and an overall complication rate of 3.8%.
